These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22393830)

  • 1. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
    Lv HX; Zhang ZH; Hui-Jiang ; Waddad AY; Zhou JP
    Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.
    Palem CR; Patel S; Pokharkar VB
    PDA J Pharm Sci Technol; 2009; 63(3):217-25. PubMed ID: 20069794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
    Shen H; Zhong M
    J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
    Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
    Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
    Khan FN; Dehghan MH
    AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
    Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS).
    Kadu PJ; Kushare SS; Thacker DD; Gattani SG
    Pharm Dev Technol; 2011 Feb; 16(1):65-74. PubMed ID: 20088679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F; Ozcan I; Guneri T
    Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
    Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
    Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micronization of atorvastatin calcium by antisolvent precipitation process.
    Zhang HX; Wang JX; Zhang ZB; Le Y; Shen ZG; Chen JF
    Int J Pharm; 2009 Jun; 374(1-2):106-13. PubMed ID: 19446766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
    Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.